KRAS, NRAS, BRAF Genes Mutations in the Tumor Substrate from Bone Marrow, ctDNA and Plasmacytomas in Multiple Myeloma (MM)

被引：0

作者：

Soloveva, Maya ^{[1
]}

Solovev, Maxim ^{[1
]}

Nikulina, Elena ^{[1
]}

Risinskaya, Natalya ^{[1
]}

Biderman, Bella ^{[1
]}

Yakutik, Igor ^{[1
]}

Obukhova, Tatyana ^{[1
]}

Sudarikov, Andrey ^{[1
]}

Julhakyan, Hunan ^{[1
]}

Mendeleeva, Larisa ^{[1
]}

机构：

[1] Natl Med Res Ctr Hematol, Moscow, Russia

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

multiple myeloma; KRAS; NRAS; BRAF; genes mutations;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MM-249

引用

页码：S485 / S485

页数：1

共 37 条

[1] KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
Pasca, Sergiu
Tomuleasa, Ciprian
Teodorescu, Patric
Ghiaur, Gabriel
Dima, Delia
Moisoiu, Vlad
Berce, Cristian
Stefan, Cristina
Ciechanover, Aaron
Einsele, Herman
[J]. FRONTIERS IN ONCOLOGY, 2019, 9
[2] BRAF, KRAS, and NRAS mutations in archival tumor samples and samples of cell-free DNA from serum and bone marrow aspirates from patients with multiple myeloma
Janku, Filip
Li, Qian
Huang, Helen J.
Wang, Yafei
Cao, Zeng
Karlin-Neumann, George
Liu, Zhiqiang
[J]. CANCER RESEARCH, 2018, 78 (13)
[3] Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma
Perroud, Camille
Thurian, Dario
Andres, Martin
Kunzi, Arnaud
Wiedemann, Gertrud
Zeerleder, Sacha
Bacher, Ulrike
Pabst, Thomas
Banz, Yara
Porret, Naomi
Rebmann, Ekaterina
[J]. HEMATOLOGICAL ONCOLOGY, 2023, 41 (05) : 912 - 921
[4] Features of the Immunophenotype of Tumor Plasmocytes in the Bone Marrow and Peripheral Blood for Multiple Myeloma Complicated By Plasmacytomas
Belousov, Kirill
Golenkov, Anatoly
Mitina, Tatiana
Chuksina, Yulia
Trifonova, Elena
Kataeva, Elena
Vysotskaya, Lyudmila
Chernykh, Yulia
Zakharov, Sergei
Mitin, Aleksandr
Shevelev, Sergei
Sverkunova, Yulia
Klinushkina, Elena
[J]. BLOOD, 2017, 130
[5] Somatic mutations in KRAS, NRAS and BRAF genes in patients with colorectal cancer from Lower Silesia Region - a preliminary report
Fulawka, L.
Hajac, L.
Glosna, M.
Michalowska, D.
[J]. VIRCHOWS ARCHIV, 2019, 475 : S99 - S99
[6] Genomic Profiles of Bone Marrow (BM) Clonal Plasma Cells (PCs) Vs Circulating Tumor Cells (CTCs) and Extramedullary (EM) Plasmacytomas in Multiple Myeloma (MM)
Bretones, Gabriel
Paiva, Bruno
Valdes-Mas, Rafael
Alignani, Diego
Garcia, Miguel
Burgos, Leire
Puente, Diana Alvarez
Agirre, Xabier
Prosper, Felipe
Lopez-Otin, Carlos
San Miguel, Jesus
[J]. BLOOD, 2016, 128 (22)
[7] Molecular Analysis Of Circulating Tumor Cells Identifies Mutations That Are Distinct From Those Present In The Bone Marrow Of Patients With Multiple Myeloma
Mishima, Yuji
Lohr, Jens
Tai, Yu-Tzu
Flores, Ludmila
Aljawai, Yosra
Laubach, Jacob P.
Richardson, Paul G.
Roccaro, Aldo M.
Anderson, Kenneth C.
Munshi, Nikhil C.
Ghobrial, Irene M.
[J]. BLOOD, 2013, 122 (21)
[8] RAS/RAF mutations in tumor samples and cell-free DNA from plasma and bone marrow aspirates in multiple myeloma patients
Li, Qian
Huang, Helen J.
Ma, Jing
Wang, Yafei
Cao, Zeng
Karlin-Neumann, George
Janku, Filip
Liu, Zhiqiang
[J]. JOURNAL OF CANCER, 2020, 11 (12): : 3543 - 3550
[9] Detection and characterization of an osteoclast stimulatory activity in freshly isolated bone marrow supernatants from patients with multiple myeloma (MM).
Cruz, JC
Choi, SJ
Chung, H
Devlin, RD
Roodman, GD
Alsina, M
[J]. BLOOD, 1998, 92 (10) : 262B - 262B
[10] Analysis of bone marrow mesenchymal stem cells (MSC) from non-Hodgkin lymphoma (NHL) and multiple myeloma (MM) patients
Villaron, EM
Almeida, J
Lopez-Holgado, N
Sanchez-Guijo, FM
San Miguel, JF
Del Cañizo, MC
[J]. EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 59 - 59

← 1 2 3 4 →